InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: alm2 post# 307446

Friday, 10/30/2020 7:15:40 AM

Friday, October 30, 2020 7:15:40 AM

Post# of 427053
Alm- Kaiser study

Collaborator:
Amarin Corporation




https://clinicaltrials.gov/ct2/show/NCT04505098?term=VASCEPA&draw=2&rank=6

Why didn’t Amarin just donate a whole bunch of Vascepa to just see if it helped / worked in covid



They/Amarin did...see Kaiser study.


Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 16500 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Pragmatic randomized clinical trial
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults (MITIGATE)
Actual Study Start Date : August 7, 2020
Estimated Primary Completion Date : August 7, 2021
Estimated Study Completion Date : February 28, 2023


BB

If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News